Table 2. Multivariate analysis: Warfarin vs. NOAC.
SEC | Thrombus | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
AF | 1.621 | 0.352–7.468 | 0.536 | |||
Age | 1.043 | 1.014–1.073 | 0.003 | 0.955 | 0.878–1.040 | 0.291 |
Sex | 0.821 | 0.439–1.537 | 0.538 | 0.365 | 0.067–1.976 | 0.242 |
CHF | 2.374 | 0.735–7.672 | 0.149 | 0.976 | 0.101–9.474 | 0.983 |
Hypertension | 1.115 | 0.642–1.937 | 0.700 | 7.301 | 1.233–43.228 | 0.028 |
Diabetes | 0.662 | 0.285–1.538 | 0.338 | 2.910 | 0.590–14.359 | 0.190 |
CVA | 1.698 | 0.683–4.218 | 0.254 | 7.107 | 1.180–42.824 | 0.032 |
PVD | 0.982 | 0.152–6.359 | 0.985 | 3.370 | 0.186–61.046 | 0.411 |
LAA flow velocity | 0.920 | 0.894–0.946 | < 0.001 | 0.881 | 0.789–0.984 | 0.025 |
LA diameter | 1.054 | 1.003–1.107 | 0.038 | 1.178 | 1.019–1.362 | 0.026 |
LV EF | 0.965 | 0.936–0.996 | 0.025 | 0.945 | 0.877–1.019 | 0.144 |
NOAC | 1.352 | 0.796–2.297 | 0.265 | 3.412 | 0.726–16.039 | 0.120 |